Being diagnosed with Hodgkin lymphoma while pregnant is frightening — but in many cases, both mother and baby can be protected with careful, trimester-by-trimester planning. This guide explains how lymphoma during pregnancy is diagnosed, timed and treated at CION.
Finding out you have Hodgkin lymphoma while you are pregnant brings two worries at once: your own health, and your baby's safety. It helps to know from the start that this situation, while rare, is well understood. Hodgkin lymphoma is one of the cancers most commonly diagnosed during the reproductive years, so specialists have decades of published experience caring for women who are Hodgkin while pregnant.
The reassuring headline is this: in many cases, both mother and baby can be protected. Lymphoma during pregnancy is managed by carefully timing tests and treatment around the stage of the pregnancy, and by having your lymphoma doctor and your obstetrician plan as one team. Treatment is not always urgent — sometimes the safest option is close monitoring until a later, safer window — and it rarely means having to choose between your care and your pregnancy.
This page explains how the diagnosis is confirmed, how staging is done safely, how treatment is timed by trimester, and what it means for the baby, breastfeeding and your future fertility. For the wider picture of lymphoma care, see our Lymphoma hub and Lymphoma Treatment in Hyderabad page.
Hodgkin lymphoma is one of the most common cancers diagnosed during pregnancy, precisely because it peaks in young adulthood — the same years many women are starting families. Published NCCN and ESMO-referenced experience shows that, when combination chemotherapy is needed, it can often be given from the second trimester onward with outcomes for the baby that approach those of the general population. The key is a coordinated haematology–obstetrics team and radiation-free staging. (Source: NCCN Hodgkin Lymphoma guidelines and ESMO clinical practice guidelines on cancer in pregnancy.)
A Hodgkin lymphoma diagnosis in pregnancy is one of the situations where the right team structure changes everything. No single doctor should make these decisions alone.
Your lymphoma specialist and a maternal-fetal (high-risk obstetric) team plan together, so the lymphoma is treated effectively while every decision is checked against your baby's safety at each stage of pregnancy.
Standard staging often uses PET-CT, which involves radiation. In pregnancy, CION relies on ultrasound and non-contrast MRI to assess the disease, protecting the baby while still guiding the plan accurately.
Every case is discussed by CION's multidisciplinary tumour board. The collective input of medical, radiation and supportive-care specialists means your plan reflects current NCCN and ESMO guidance, not one person's opinion.
These are emotional decisions. We take time to explain the evidence, answer questions from you and your family, and offer a free written second opinion so you feel confident — never rushed — about the path ahead.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
You don't have to make these decisions alone. Speak to CION's lymphoma team, working hand in hand with maternal-fetal specialists, for a clear, compassionate plan built around you and your baby.
Hodgkin lymphoma can be harder to spot during pregnancy, because some of its signs — tiredness, breathlessness, mild breast or chest discomfort — overlap with normal pregnancy changes. The most typical sign is a painless, firm, swollen lymph node, most often in the neck, above the collarbone, or in the armpit, that persists rather than settling. Other signs that deserve prompt review include:
Most swollen glands in pregnancy are harmless. But a node that is painless, firm and persistent should always be checked — a simple ultrasound and, if needed, a biopsy can settle the question quickly and safely. Speak to a CION lymphoma specialist if you have these signs or a confirmed diagnosis.
The diagnostic goal is the same as at any other time — confirm the disease, its subtype and its extent — but the tools are chosen to keep the baby safe.
A biopsy of the enlarged node (usually an excision biopsy) is what actually confirms Hodgkin lymphoma, and it can be performed safely at any point in pregnancy. Looking at the tissue also lets the pathologist identify the subtype — for example, classical Hodgkin lymphoma or the less common nodular lymphocyte-predominant type — using markers such as CD30 and CD15. Knowing the subtype shapes the plan.
Outside pregnancy, staging usually relies on PET-CT, which uses ionising radiation. During pregnancy this is generally avoided. Instead, the team uses ultrasound and non-contrast MRI, which do not use radiation, to map where the lymphoma is. A chest assessment can be done with shielding and careful technique when essential. This gives enough information to plan treatment without unnecessary risk to the baby.
Routine blood tests help assess your overall health and organ function, and a bone-marrow examination — safe in pregnancy — is done only if it is needed to complete the picture. For a fuller explanation of the disease itself and how it differs from other types, see our Hodgkin lymphoma overview.
A lymph-node biopsy — the test that actually confirms Hodgkin lymphoma — is considered safe at any stage of pregnancy. It is the radiation-based staging scans (CT and PET-CT), not the biopsy, that teams work to avoid during pregnancy by substituting ultrasound and non-contrast MRI. This means a firm diagnosis need never be delayed out of fear for the baby, even while the fuller staging is done using radiation-free methods. (Source: ESMO clinical practice guidelines on cancer, fertility and pregnancy.)
The single biggest factor in planning Hodgkin lymphoma treatment during pregnancy is timing — both how many weeks pregnant you are and how the disease is behaving. The table below is a general guide only; your own plan is decided by the combined haematology–obstetrics team and reviewed by the tumour board.
| Stage of pregnancy | Usual approach | Why |
|---|---|---|
| First trimester | Close monitoring where the disease allows; treatment deferred to the second trimester if safe. Modified treatment only if disease is aggressive. | The baby's organs are forming, so chemotherapy and radiation carry the highest risk in this window. |
| Second trimester | Combination chemotherapy can usually be started when treatment is needed, delivered directly by CION with close monitoring. | Organ development is largely complete; published series report outcomes for the baby approaching the general population. |
| Third trimester | Treatment continued as needed, with delivery timing planned jointly; some therapy may be deferred until after birth. | The team balances controlling the lymphoma with allowing safe delivery and recovery. |
General guide only; individual plans vary and are set by your combined care team following NCCN and ESMO guidance.
When treatment is required, combination chemotherapy is the mainstay for Hodgkin lymphoma, delivered directly by CION's medical oncology team. From the second trimester it can often be given with careful monitoring of both mother and baby. Specific drug regimens are individualised and discussed on the Lymphoma Treatment in Hyderabad page rather than here.
Radiation to areas away from the abdomen — for example the chest — can sometimes be used with careful shielding, but it is often deferred until after delivery where possible. When used, CION delivers precision radiation (IMRT) directly, with technique chosen to minimise any dose reaching the baby.
More intensive options such as stem-cell transplant, which is relevant mainly in relapsed Hodgkin lymphoma, are not delivered in pregnancy; when needed they are arranged through accredited partner facilities and timed after delivery. CION coordinates these referrals while delivering chemotherapy, radiation, monitoring and supportive care directly.
Hodgkin lymphoma is among the more treatable lymphomas. Published series report roughly 80–90% long-term survival overall (for comparison, aggressive non-Hodgkin lymphomas such as DLBCL report around 60–70%), though these are population figures and vary considerably by stage, subtype and individual factors — they are not a personal prediction. Current evidence indicates that being pregnant does not, by itself, make the outlook meaningfully worse when the disease is properly staged and appropriately treated. You can read more on our Hodgkin lymphoma survival & cure rates page.
Breastfeeding: during active chemotherapy, breastfeeding is generally paused because drugs can pass into milk; after treatment and an appropriate clearance interval, many mothers can breastfeed. Fertility: for many women, fertility is preserved, but this depends on the treatment used and your age, so fertility preservation should ideally be discussed before treatment starts. If you are planning a family after recovery, our pregnancy after lymphoma treatment guide covers the timing and safety in detail. Younger patients can also read about the wider picture on our Hodgkin lymphoma in young adults page.
A second opinion is especially valuable when lymphoma and pregnancy overlap, because the decisions are finely balanced:
CION offers a dedicated, free written second-opinion service. You deserve a plan built around healing both you and your baby — with transparent costs explained up front. Request your free second opinion or call 18002028726. You can also explore our lymphoma hospital in Hyderabad and Hodgkin lymphoma symptoms pages.
Get a free written second opinion from CION's lymphoma team, working alongside maternal-fetal specialists — especially valuable if you have been given difficult advice before all options were explored.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.In many cases, yes — with careful, coordinated planning. Hodgkin lymphoma is one of the cancers most often diagnosed during the reproductive years, and a large body of published experience shows that many pregnancies can continue while the mother is treated, or safely monitored until treatment is safest to start. The approach depends heavily on the trimester, how the disease is behaving, and where the lymphoma sits. Decisions are made by a combined team of a haematologist–oncologist and an obstetrician working together. At CION, every case is reviewed by a multidisciplinary lymphoma tumour board alongside maternal-fetal specialists so that both mother and baby are protected. NCCN and ESMO both recognise that treatment can often be delivered without terminating the pregnancy.
Diagnosis follows the same principle as outside pregnancy — a lymph-node biopsy (usually an excision biopsy) confirms Hodgkin lymphoma and is safe at any stage of pregnancy. What changes is the staging (imaging) approach. PET-CT and CT use ionising radiation and are generally avoided; instead, teams rely on ultrasound and non-contrast MRI, which do not use radiation, to assess the extent of disease. Blood tests and a bone-marrow examination can still be done when needed. This modified workup lets doctors understand the disease without exposing the baby to unnecessary radiation. For a broader overview of testing, see our what is Hodgkin lymphoma guide, and discuss your own scans with our team via the free consultation form.
The risk depends mainly on timing. Chemotherapy given in the first trimester, when the baby's organs are forming, carries the highest risk and is usually avoided if possible. From the second trimester onward, published series report that combination chemotherapy for Hodgkin lymphoma can often be given with outcomes for the baby that are close to those of the general population, though close monitoring is essential. Radiation to the chest and other treatments are timed and shielded carefully, and some therapies are deferred until after delivery. Every plan weighs the mother's need to treat active lymphoma against protecting the pregnancy. This is exactly why a coordinated haematology–obstetrics team, as offered at CION, matters — the balance is individual. NCCN and ESMO guidance informs these decisions.
The first trimester is the most delicate window, because the baby's organs are developing and both chemotherapy and radiation carry more risk during this time. If the Hodgkin lymphoma is slow-moving and the mother is well, the team may choose to monitor closely and delay treatment until the second trimester, when therapy is generally safer. If the disease is aggressive or the mother has significant symptoms, the team discusses the options honestly with the family — which may include starting a modified treatment, or in some situations considering the timing of the pregnancy itself. These are deeply personal decisions made together with you, your obstetrician and the lymphoma specialists. There is rarely a single right answer, and CION's role is to lay out the evidence clearly and support your choice.
Current published evidence is reassuring: for most women, being pregnant does not appear to make Hodgkin lymphoma more aggressive or meaningfully worsen long-term survival, provided the disease is properly staged and appropriately treated. Hodgkin lymphoma is among the more treatable lymphomas — published series report roughly 80–90% long-term survival overall, though figures vary by stage, subtype and individual factors. The key is not to leave active disease untreated for too long out of fear for the baby, because a coordinated plan can usually protect both. For more on outlook, see our Hodgkin lymphoma survival & cure rates page. These figures are drawn from published NCCN/ESMO-referenced series and are general, not personal predictions.
It depends on the treatment and its timing. While actively receiving chemotherapy, breastfeeding is generally not advised, because drugs can pass into breast milk. Once treatment is complete and after an appropriate clearance interval advised by your team, many mothers can breastfeed safely. If treatment is deferred until after delivery, your doctors will plan the timing of feeding around each cycle. These details are always discussed individually, because they depend on the specific therapy used. Our team routes any regimen-specific questions to the lymphoma treatment plan discussion, where the medical oncologist can advise on your exact schedule.
For many women treated for Hodgkin lymphoma, fertility is preserved, but this depends on the type and intensity of treatment and your age. Some treatments carry a higher risk to future fertility than others. Because of this, fertility preservation options should ideally be discussed before treatment starts wherever the timeline allows. If you are thinking about pregnancy after completing treatment, our dedicated pregnancy after lymphoma treatment page explains the timing, monitoring and safety considerations. CION's team can arrange a fertility discussion as part of your overall plan so that survivorship and family planning are considered from the start.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.